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Repeated treatment with psychostimulant drugs causes long-
lasting behavioral sensitization and associated neuroadapta-
tions. Although sensitization induced by a single psychostimu-
lant exposure has also been reported, information on the
behavioral and neurochemical consequences of a single psy-
chostimulant exposure is sparse. Therefore, to evaluate
whether behavioral sensitization evoked by single and repeated
psychostimulant pretreatment regimens represent the same
neurobiological phenomenon, the time-dependent expression
of behavioral, neurochemical, and neuroendocrine sensitization
after a single exposure to amphetamine was investigated in
rats. A single exposure to amphetamine (5 mg/kg, i.p.) caused
context-independent sensitization of the locomotor effects of
amphetamine, which intensified over time. Thus, sensitization
to amphetamine was marginal at 3 d after treatment and more
evident after 1 week, whereas 3 weeks after treatment, pro-
found sensitization, as well as cross-sensitization, to cocaine
was observed. Amphetamine pretreatment caused an increase
in the electrically evoked release of [3H]dopamine from nucleus
accumbens, caudate putamen, and medial prefrontal cortex
slices and of [14C]acetylcholine from accumbens and caudate
slices. The hyperreactivity of dopaminergic nerve terminals ap-
peared to parallel the development of locomotor sensitization,
i.e., whereas hyperreactivity of accumbens dopaminergic ter-
minals increased between 3 d and 3 weeks after treatment, the
hyperreactivity of medial prefrontal dopaminergic terminals de-
creased. Pre-exposure to amphetamine also sensitized the
hypothalamus–pituitary–adrenal axis response to amphetamine
at 1 and 3 weeks, but not at 3 d after treatment. Because these
data closely resemble those reported previously for repeated
amphetamine pretreatment, it is concluded that a single expo-
sure to amphetamine is sufficient to induce long-term behav-
ioral, neurochemical, and neuroendocrine sensitization in rats.
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Repeated exposure to drugs of abuse results in a progressive and
enduring enhancement of their psychomotor and positive rein-
forcing effects. This phenomenon, termed behavioral sensitiza-
tion (Stewart and Badiani, 1993), is thought to underlie certain
aspects of drug addiction and drug-induced psychosis (Robinson
and Becker, 1986; Robinson and Berridge, 1993; De Vries et al.,
1998). The expression of behavioral sensitization relies on time-
dependent neuroplastic changes in the brain circuitry involved in
motivational behavior. Of the numerous neuroadaptive phenom-
ena involved, long-lasting hyperreactivity of the mesolimbic do-
paminergic pathway has received most attention (for review, see
Pierce and Kalivas, 1997).
The extent to which sensitization is induced by drug pre-
exposure is highly dependent on the nature of the pretreatment
regimen. Thus, repeated intermittent treatment with moderate
doses of drugs is far more effective in inducing sensitization than
chronic exposure to high or escalating drug doses (Post, 1980;
Robinson and Becker, 1986; Stewart and Badiani, 1993; Vander-
schuren et al., 1997). Interestingly, next to repeated intermittent
and chronic administration schedules, which both use multiple
drug exposures, even a single exposure to amphetamine or co-
caine has been found to induce behavioral and neurochemical
sensitization (Robinson et al., 1982; Robinson, 1984; Peris and
Zahniser, 1987; Kalivas and Alesdatter, 1993). However, it is not
clear whether sensitization induced by single and repeated psy-
chostimulant exposure represents the same neurobiological phe-
nomenon. For example, whereas there is a wealth of data on the
neuroadaptive consequences of repeated psychostimulant treat-
ment (for review, see White et al., 1995; Pierce and Kalivas, 1997;
Wolf, 1998), information on the neuroadaptive effects of a single
psychostimulant exposure is sparse (Robinson et al., 1982; Peris
and Zahniser, 1987). Furthermore, repeated psychostimulant
treatment can induce behavioral sensitization in both a context-
dependent and a context-independent manner (Stewart and Dru-
han, 1993; Anagnostaras and Robinson, 1996; Robinson et al.,
1998; Vanderschuren et al., 1999a). However, sensitization after a
single drug pretreatment has only been investigated in a context-
dependent manner, meaning that tests for sensitization were
performed in the same environment in which pretreatment took
place, allowing for association of environmental cues with drug
effects. In view of the differences between context-dependent and
context-independent behavioral sensitization, both behaviorally
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(Anagnostaras and Robinson, 1996; Robinson et al., 1998) and
neurobiologically (Hoffman and Wise, 1992; Li et al., 1997; Mead
and Stephens, 1998), it is of interest to investigate whether
context-independent sensitization also occurs after a single psy-
chostimulant exposure.
For these reasons, we evaluated the time-dependent behav-
ioral, neurochemical, and neuroendocrine effects of a single ex-
posure to amphetamine (5 mg/kg, IP) and compared them with
the effects observed previously after repeated amphetamine treat-
ment. Thus, the time course of amphetamine-induced context-
independent sensitization to the locomotor effects of amphet-
amine, as well as long-term cross-sensitization to cocaine and
direct dopamine receptor agonists, was investigated. In addition,
at various post-treatment intervals, we investigated the effect of
amphetamine pre-exposure on the electrically evoked release of
[3H]dopamine and [14C]acetylcholine from slices of nucleus ac-
cumbens, caudate putamen, and medial prefrontal cortex and on
the secretion of ACTH and corticosterone elicited by a challenge
with amphetamine.
MATERIALS AND METHODS
Animals and amphetamine pretreatment. All experiments were approved
by the Animal Care Committee of the Free University of Amsterdam.
Male Wistar rats (Harlan CPB, Zeist, The Netherlands), weighing 180–
200 gm at the time of amphetamine or saline pretreatment, were housed
two per cage in Macrolon cages under controlled conditions (lights on
from 7:00 A.M. to 7:00 P.M.). Animals were allowed to accustom to the
housing conditions for at least 1 week before use. Food and water were
available ad libitum. Animals were briefly handled on the 2 d preceding
pretreatment and on the 2 d preceding subsequent drug challenges.
Pretreatment consisted of a single injection with amphetamine (5 mg/kg,
i.p.) or saline (1 ml/kg, i.p.), administered in the home cage. Amphet-
amine was dissolved in sterile saline.
Determination of locomotor activity. Horizontal motor activity was
measured in perspex cages (40 3 40 3 35 cm) using a video tracking
system (EthoVision; Noldus Information Technology B.V., Wageningen,
The Netherlands), which determined the position of the animal five times
per second. Experiments were started at approximately 9:30 A.M.
White-noise was used to minimize the influence of surrounding sounds.
Locomotor challenge tests were conducted as follows. Animals were
allowed to habituate to the test cages for 2 hr, during which activity was
monitored. Then, animals received an injection with saline (1.0 ml/kg,
s.c. or i.p., depending on the route of administration of the challenge
drug), and activity was monitored for 1 hr. Subsequently, animals were
injected with amphetamine (1 mg/kg, i.p.), cocaine (15 mg/kg, i.p.), the
dopamine D1 receptor agonist SKF-82958 (1 mg/kg, s.c.), the dopamine
D2 receptor agonist quinpirole (0.5 mg/kg, s.c.), or the nonselective
dopamine agonist apomorphine (0.3 mg/kg, s.c.). To examine the time
course of amphetamine sensitization, locomotor challenges with amphet-
amine were performed 3 d, 1 week, or 3 weeks after treatment. To
examine the occurrence of long-term cross-sensitization to cocaine, SKF-
82958, quinpirole, and apomorphine, locomotor challenges with these
drugs were performed 3 weeks after treatment. The challenge doses of
the drugs represent the doses used previously to investigate dopaminer-
gic mechanisms involved in the expression of locomotor sensitization
induced by repeated amphetamine treatment (Vanderschuren et al.,
1999a). Animals were challenged only once. All drugs were dissolved in
sterile saline.
Determination of neurotransmitter release. Three days or 3 weeks after
treatment, rats pre-exposed to saline or amphetamine were decapitated,
and nucleus accumbens, caudate putamen, and medial prefrontal cortex
were rapidly dissected. Tissue slices (0.3 3 0.3 3 1 mm) were prepared
using a McIlwain tissue chopper and superfused as described previously
(Schoffelmeer et al., 1994; Nestby et al., 1997). Slices (pooled tissue of
two to three rats) were washed twice with Krebs’–Ringer’s bicarbonate
medium containing (in mM) 121 NaCl, 1.87 KCl, 1.17 KH2PO4, 1.17
MgSO4, 1.22 CaCl2, 25 NaHCO3, and 10 D-(1)-glucose, and subse-
quently incubated for 15 min in this medium under a constant atmo-
sphere of 95% O2–5% CO2 at 37°C. After preincubation, the slices were
rapidly washed and incubated for 15 min in 2.5 ml of medium containing
5 mCi [ 3H]dopamine and 2 mCi [ 14C]choline, under an atmosphere of
95% O2–5% CO2 at 37°C. Because the nucleus accumbens and medial
prefrontal cortex have a dense noradrenergic innervation, 3 mM desipra-
mine was added during incubation to prevent accumulation of [ 3H]do-
pamine in noradrenergic nerve terminals. After labeling, the slices were
rapidly washed and transferred to each of 24 chambers of a superfusion
apparatus (;4 mg of tissue in 0.2 ml volume per chamber) and super-
fused (0.20 ml/min) with medium gassed with 95% O2–5% CO2 at 37°C.
In each experiment, neurotransmitter release from slices of saline- and
amphetamine-pretreated rats was studied simultaneously in 24 parallel
superfusion chambers. The superfusate was collected as 10 min samples
after 40 min of superfusion (t 5 40 min). Ca 21-dependent neurotrans-
mitter release was induced during superfusion by exposing the slices to
electrical biphasic block pulses (1 Hz, 30 mA, 2 msec pulses for nucleus
accumbens and caudate putamen slices; and 1 Hz, 15 mA, 2 msec pulses
for medial prefrontal cortex slices) for 10 min at t 5 50 min (electrical
field stimulation).
The radioactivity remaining at the end of the experiment was ex-
tracted from the tissue with 0.1 N HCl. The radioactivity in superfusion
fractions and tissue extracts was determined by liquid scintillation count-
ing. The efflux of radioactivity during each collection period was ex-
pressed as a percentage of the amount of radioactivity in the slices at the
beginning of the respective collection period. The electrically evoked
release of neurotransmitter was calculated by subtracting the spontane-
ous efflux of radioactivity from the total overflow of radioactivity during
stimulation and the next 10 min. A linear decline from the 10 min
interval before to that 20–30 min after the start of stimulation was
assumed for calculation of the spontaneous efflux of radioactivity. The
release evoked was expressed as percentage of the content of radioac-
tivity of the slices at the start of the stimulation period.
Determination of hypothalamus–pituitary–adrenal axis activity. After a
post-treatment interval of 3 d, 1 week, or 3 weeks, saline- or
amphetamine-pretreated rats were injected with amphetamine (1 mg/kg,
i.p.), placed back into their home cages, and decapitated 20 min later.
Trunk blood was collected in ice-cold heparin-coated tubes and centrifu-
gated (1000 3 g, 15 min, 4°C). Aliquots of plasma were stored at 220°C
until assayed. ACTH concentrations were measured as described previ-
ously (Van Oers et al., 1992) using antiserum 8514 against the midportion
of ACTH (Kovacs and Makara, 1988). Synthetic rat ACTH was used as
a standard. The sensitivity of the assay was 10 pg/ml plasma (0.5 pg/
tube). Plasma ACTH concentrations were expressed as pg/ml plasma.
Plasma corticosterone levels were determined by radioimmunoassay
(ICN Biochemicals, Costa Mesa, CA) and expressed as nanograms per
milliliter plasma. The sensitivity of the assay was 0.7 ng/ml plasma.
Radiochemicals and drugs. [ 3H]Dopamine (47 Ci/mmol) and [ 14C]cho-
line (15 mCi/mmol) were purchased from the Radiochemical Center
(Amersham Pharmacia Biotech, Buckinghamshire, UK). ACTH was
purchased from Peninsula Laboratories (Belmont, CA). Desipramine,
dopamine, and (2)-sulpiride were purchased from Sigma (St. Louis,
MO). Morphine-HCl, (1)-amphetamine sulfate, cocaine-HCl, and
apomorphine-HCl were purchased from O.P.G. (Utrecht, The Nether-
lands), (6)-SKF-82958-HBr and (2)-quinpirole-HCl were from Re-
search Biochemicals (Natick, MA).
Statistics. Horizontal locomotor activity, expressed as distance traveled
(in centimeters) was calculated in 10 min blocks. Locomotor activity was
analyzed using two-factor repeated-measures ANOVA for time block
and pretreatment. Post hoc comparisons were performed using Student–
Newman–Keuls tests. In vitro neurotransmitter release and plasma
ACTH and corticosterone concentrations were calculated as percentage
of values from saline-pretreated rats in the respective experiment. Ob-
servations of different experiments were pooled and analyzed using
one-way ANOVA.
RESULTS
Time-dependent locomotor sensitization
to amphetamine
The locomotor effects of amphetamine (1 mg/kg, i.p.) in saline-
and amphetamine-pretreated rats after various post-treatment
intervals are presented in Figure 1A–C. The locomotor effect of
amphetamine was enhanced in rats pre-exposed to amphetamine
at 3 d, 1 week, and 3 weeks after treatment, but to a different
degree. Three days after exposure, the locomotor effects of am-
phetamine were only marginally affected by amphetamine pre-
treatment (pretreatment, F(1,44) 5 0.04; NS; pretreatment 3 time,
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F(8,352) 5 3.29; p , 0.01), sensitization being evident during the
second 10 min time block only (Fig. 1A). One week after treat-
ment, a more marked amphetamine pretreatment effect was
found (pretreatment, F(1,30) 5 3.45; p 5 0.07;) pretreatment 3
time, F(8,240) 5 3.82; p , 0.0001). In amphetamine-pre-exposed
rats, the locomotor effects of amphetamine were enhanced during
the first three 10 min time blocks (Fig. 1B). A clear-cut sensiti-
zation of the locomotor effects of amphetamine in amphetamine-
pre-exposed animals was observed 3 weeks after treatment
(pretreatment, F(1,27) 5 11.48; p , 0.01; pretreatment 3 time,
F(8,216) 5 2.58; p , 0.05). Post hoc analysis showed a significant
enhancement of amphetamine-induced hyperlocomotion during
the first six 10 min time blocks (Fig. 1C). Pretreatment with
amphetamine did not result in altered locomotion during the
habituation phases (data not shown) and the challenges with
saline, irrespective of the post-treatment interval at which testing
was performed (Fig. 1A–C).
Long-term cross-sensitization to cocaine and
dopamine receptor agonists
The long-term effects of a single pre-exposure to 5 mg/kg am-
phetamine on locomotor activity induced by cocaine and dopa-
mine receptor agonists are presented in Figure 2. Three weeks
after treatment, amphetamine-pre-exposed rats were sensitized
to the locomotor effects of cocaine (15 mg/kg, i.p.) (pretreatment,
F(1,13) 5 4.49; p 5 0.05; pretreatment 3 time, F(8,104) 5 2.41; p ,
0.05). Post hoc analysis revealed a significant enhancement of the
locomotor effect of cocaine during three 10 min time blocks (Fig.
2A). In animals pretreated with amphetamine, the locomotor
effect of the D1 receptor agonist SKF-82958 was altered. The
overall locomotor effect of SKF-82958 appeared not to be
affected at all by amphetamine pretreatment (total distance
traveled, 14053 6 2919 cm in saline-pre-exposed rats and
13794 6 3223 cm in amphetamine-pre-exposed rats; pretreat-
ment, F(1,30) 5 0.00; NS). However, the time course of SKF-82958
locomotion was altered in amphetamine-pre-exposed animals
(pretreatment 3 time, F(14,420) 5 3.48; p , 0.0001); post hoc tests
revealed a significant increase in the locomotor effect of SKF-
82958 in amphetamine-pretreated rats during the first two 10 min
time blocks (Fig. 2B). When saline- and amphetamine-pretreated
rats were challenged with the D2 receptor agonist quinpirole, a
tendency toward sensitization in amphetamine-pretreated rats
was found (pretreatment, F(1,12) 5 4.24; p 5 0.06; pretreatment 3
time, F(23,276) 5 0.85; NS) (Fig. 2C). The locomotor effects of the
nonselective dopamine receptor agonist apomorphine did not
differ between rats pretreated with saline and amphetamine (pre-
treatment, F(1,14) 5 0.36; NS; pretreatment 3 time, F(8,112) 5
1.81; NS) (Fig. 2D). Amphetamine pre-exposure did not result in
altered locomotion during the habituation phases (data not
shown) and the challenges with saline (Fig. 2A–D).
Time-dependent adaptive changes in forebrain
dopamine and acetylcholine neurotransmission
Studying the electrically evoked release of [3H]dopamine and
[ 14C]acetylcholine, the effect of amphetamine pretreatment on
the reactivity of dopaminergic and cholinergic nerve terminals in
nucleus accumbens, caudate putamen, and medial prefrontal cor-
tex toward depolarization was investigated 3 d and 3 weeks after
treatment. In slices of saline-pretreated rats, the electrically stim-
ulated [ 3H]dopamine release in excess of spontaneous [ 3H] efflux
in slices of nucleus accumbens, caudate putamen, and medial
prefrontal cortex amounted to 1.6 6 0.1, 2.4 6 0.2, and 3.8 6
0.2% of total tissue radioactivity, respectively. The electrically
stimulated [ 14C]acetylcholine release in excess of spontaneous
[ 14C] efflux in slices of nucleus accumbens and caudate putamen,
respectively, amounted to 4.2 6 0.3 and 6.0 6 0.4% of total tissue
radioactivity. Because the electrically evoked release of [14C]ace-
tylcholine from medial prefrontal cortex slices hardly exceeded
the spontaneous efflux of radioactivity, [ 14C]acetylcholine release
data from medial prefrontal cortex slices are not presented.
As shown in Figure 3, the responsiveness of all types of nerve
terminals investigated was increased at both time points as a
Figure 1. Locomotor responses to amphetamine (1 mg/kg, i.p.) in rats
pretreated with amphetamine [AMPH; 1 3 5 mg/kg, i.p.; n 5 22 (A); n 5
16 (B); n 5 14 (C); filled circles] or saline [SAL; n 5 24 (A); n 5 16 (B);
n 5 15 (C); open circles] 3 d (A), 1 week (B), or 3 weeks (C) after
treatment. After 2 hr habituation to the test cages, the animals were
injected with saline (1 ml/kg, i.p.) and 1 hr later with amphetamine, after
which activity was monitored for 1.5 hr. Data are expressed as mean 6
SEM traveled distance (in centimeters) per 10 min interval. *p , 0.05,
different from saline-pretreated rats (Student–Newman–Keuls).
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consequence of amphetamine pretreatment. In nucleus accum-
bens slices, the amphetamine-induced hyperreactivity of dopa-
minergic nerve terminals increased over time (3 d vs 3 weeks,
F(1,76) 5 4.41; p , 0.05), from a 41% increase 3 d (F(1,63) 5 12.35;
p , 0.001) to a 69% increase 3 weeks (F(1,83) 5 39.31; p , 0.0001)
after treatment. On the other hand, the responsiveness of cholin-
ergic nerve terminals in nucleus accumbens slices as a result of
pretreatment with amphetamine was enhanced to a similar de-
gree at both time points: 39% at 3 d (F(1,65) 5 12.21; p , 0.001)
and 41% at 3 weeks (F(1,85) 5 32.64; p , 0.0001) after treatment
(Fig. 3A). The neuroadaptive effects of amphetamine-
pretreatment observed in caudate putamen were comparable but
smaller than those found in the accumbens. The hyperrespon-
siveness of dopaminergic nerve terminals increased, from an
enhancement of 20% at 3 d (F(1,58) 5 6.97; p , 0.05) to 34% at
3 weeks (F(1,55) 5 16.50; p , 0.001) after treatment, but this time
effect was not significant (3 d vs 3 weeks, F(1,56) 5 2.11; NS).
Amphetamine-induced hyperreactivity of cholinergic nerve ter-
minals in caudate putamen slices was comparable at both time
points: 37% at 3 d (F(1,55) 5 16.82; p , 0.001) and 34% at 3 weeks
(F(1,66) 5 12.67; p , 0.001) after treatment (Fig. 3B). With regard
to hyperresponsiveness of dopaminergic nerve terminals in me-
dial prefrontal cortex slices, a picture opposite from that observed
in accumbens and caudate slices emerged. As a result of pre-
exposure to amphetamine, neuronal responsiveness was in-
creased at 3 d after treatment by 78% (F(1,30) 5 38.14; p ,
0.0001), and this effect significantly declined (3 d vs 3 weeks,
F(1,37) 5 12.90; p , 0.01) to a 36% increase at 3 weeks after
treatment (F(1,41) 5 24.01; p , 0.0001) (Fig. 3C).
Time-dependent sensitization of the
hypothalamus–pituitary–adrenal axis
The effects of amphetamine (1 mg/kg, i.p.) on plasma concentra-
tions of ACTH and corticosterone in rats pretreated with saline
or amphetamine are presented in Figure 4, A and B, respectively.
There was a considerable variation between experiments regard-
ing the magnitude of neuroendocrine parameters determined. In
saline-pretreated rats, amphetamine-induced plasma concentra-
tions of ACTH varied between 51.7 6 9.4 and 148.4 6 11.0 pg/ml
and plasma corticosterone between 43.3 6 5.4 and 121.2 6 15.1
ng/ml. Despite this variation, there were clear-cut effects of am-
phetamine pre-exposure on hypothalamus–pituitary–adrenal
axis reactivity to amphetamine. Three days after treatment, no
effect of amphetamine pre-exposure on the amphetamine-
induced increase in the secretion of ACTH (F(1,8) 5 0.03; NS)
(Fig. 4A) and corticosterone (F(1,8) 5 0.21; NS) (Fig. 4B) was
observed. One week after treatment, the amphetamine-induced
increase in both ACTH and corticosterone secretion were signif-
icantly augmented in amphetamine-pretreated rats; the secretion
of ACTH was increased by 43% (F(1,9) 5 7.06; p , 0.05) (Fig. 4A)
and the secretion of corticosterone by 84% (F(1,8) 5 8.31; p ,
0.05) (Fig. 4B). Comparable effects were observed at 3 weeks
after treatment, i.e., in animals pretreated with amphetamine,
amphetamine-induced ACTH concentrations were increased by
34% (F(1,9) 5 5.50; p , 0.05) (Fig. 4A) and corticosterone
concentrations by 73% (F(1,11) 5 18.03; p , 0.01) (Fig. 4B).
DISCUSSION
The main finding in the present study is that a single exposure to
amphetamine (5 mg/kg, i.p.) causes long-lasting behavioral sen-
sitization associated with neurochemical and neuroendocrine ad-
aptations. Amphetamine-induced behavioral sensitization was
Figure 2. Locomotor responses to cocaine (15 mg/kg, i.p.; A), SKF-82958
(1 mg/kg, s.c.; B), quinpirole (0.5 mg/kg, s.c.; C), or apomorphine (0.3
mg/kg, s.c.; D) in rats pretreated with amphetamine [AMPH; 1 3 5 mg/kg,
i.p.; n 5 8 (A); n 5 16 (B); n 5 7 (C); n 5 8 (D); filled circles] or saline
[SAL; n 5 7 (A); n 5 16 (B); n 5 7 (C); n 5 8 (D); open circles] 3 weeks
after treatment. After 2 hr habituation to the test cages, the animals were
injected with saline (1 ml/kg, s.c. or i.p.) and 1 hr later with the challenge
drug, after which activity was monitored for 1.5–4 hr. Data are expressed as
mean 6 SEM traveled distance (in centimeters) per 10 min interval. *p ,
0.05, different from saline-pretreated rats (Student–Newman–Keuls).
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expressed in a context-independent manner and gradually devel-
oped after pretreatment, with sensitization being most pro-
nounced at 3 weeks after treatment. Moreover, a long-lasting
cross-sensitization to cocaine and a tendency toward cross-
sensitization to the dopamine D2 receptor agonist quinpirole was
found after pre-exposure to amphetamine. Amphetamine pre-
treatment caused a time-dependent hyperreactivity toward depo-
larization of dopaminergic nerve terminals in the nucleus accum-
bens, caudate putamen, and medial prefrontal cortex and
cholinergic nerve terminals in nucleus accumbens and caudate
putamen. In addition, a delayed hyperreactivity of the hypothala-
mus–pituitary–adrenal axis toward an amphetamine challenge
was induced by amphetamine pretreatment. Together, the effects
of a single exposure to amphetamine closely resemble those we
(Nestby et al., 1997; Schmidt et al., 1999; Vanderschuren et al.,
1999a,b) and others (for review, see Pierce and Kalivas, 1997)
have found previously after repeated amphetamine pretreatment.
We therefore conclude that a single exposure to amphetamine is
sufficient to induce long-lasting behavioral, neurochemical, and
neuroendocrine sensitization in rats.
Long-term behavioral sensitization evoked by a single psycho-
stimulant exposure has been reported previously, but the present
study is the first to show that this can occur in a context-
independent manner, meaning that pretreatment and challenge
injections were administered in separate environments. In this
respect, it is important to note that during neither habituation
phases nor saline challenges locomotor activity differed between
amphetamine- and saline-pretreated rats. This indicates that am-
phetamine pretreatment did not induce changes in basal or
novelty-induced locomotion or a conditioned psychomotor re-
sponse to the injection. Therefore, the observed locomotor sen-
sitization most likely represents a nonassociative increase in the
sensitivity to the locomotor effects of psychostimulant drugs, as a
result of neuroadaptive changes induced by amphetamine
pretreatment.
With regard to locomotor sensitization, the pattern of effects
evoked by a single pre-exposure to amphetamine strikingly re-
sembled that induced by repeated amphetamine pretreatment.
Thus, the magnitude of amphetamine-induced sensitization to
the locomotor effects of amphetamine gradually increased with
prolonged withdrawal (i.e., between 3 d and 3 weeks after treat-
ment), which has also been observed after repeated amphetamine
pretreatment (Kolta et al., 1985; Paulson et al., 1991; Vanders-
churen et al., 1999b). In addition, just like repeated amphetamine
pretreatment (Conway and Uretsky, 1982; Robinson, 1984; Kali-
vas and Weber, 1988; Vanderschuren et al., 1999a,b), single
amphetamine caused cross-sensitization to cocaine but not to
morphine and apomorphine. Also, both regimens induced cross-
sensitization to quinpirole but to different degrees, i.e., a robust
sensitization after repeated amphetamine (Ujike et al., 1990;
Vanderschuren et al., 1999a), whereas cross-sensitization to quin-
pirole after single amphetamine just failed to reach statistical
Figure 4. Plasma concentrations of ACTH ( A) and corticosterone ( B) induced by a challenge with amphetamine in rats pretreated with amphetamine
(AMPH; 1 3 5 mg/kg, i.p.; filled bars) or saline (SAL; open bars) 3 d, 1 week, or 3 weeks after treatment. Groups of rats (n 5 4–6) were injected with
amphetamine (1 mg/kg, i.p.) in their home cages and decapitated 20 min later. Trunk blood was collected, and plasma ACTH and corticosterone
concentrations were determined by radioimmunoassay. Results are presented as percentage of plasma concentrations in saline-pretreated rats. Values
represent means 6 SEM. *p , 0.05; **p , 0.01, different from saline pretreatment (ANOVA).
Figure 3. A, Enhancement of the electrically evoked release of [ 3H]dopamine and [ 14C]acetylcholine from superfused nucleus accumbens slices of rats
as a result of pre-exposure to amphetamine (1 3 5 mg/kg, i.p.) 3 d (open bars) or 3 weeks ( filled bars) after treatment. B, Enhancement of the electrically
evoked release of [ 3H]dopamine and [ 14C]acetylcholine from superfused caudate putamen slices of rats as a result of pre-exposure to amphetamine (1 3
5 mg/kg, i.p.) 3 d (open bars) or 3 weeks ( filled bars) after treatment. C, Enhancement of the electrically evoked release of [ 3H]dopamine from
superfused medial prefrontal cortex slices of rats as a result of pre-exposure to amphetamine (1 3 5 mg/kg, i.p.) 3 d (open bars) or 3 weeks ( filled bars)
after treatment. Data are expressed as percent increase above electrically evoked release in slices of saline-pretreated rats and represent means 6 SEM
of 15–45 observations. *p , 0.05; **p , 0.001; ***p , 0.0001, different from saline pretreatment (ANOVA); 1p , 0.05; 11p , 0.01, 3 d after treatment
differs from 3 weeks after treatment (ANOVA).
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significance. There was a slight difference between single and
repeated amphetamine with regard to the onset of the locomotor
response to SKF-82958, which appeared to be somewhat faster
after single amphetamine but slower after repeated amphetamine
(Vanderschuren et al., 1999a). The reason for this discrepancy
remains to be clarified.
Neuroadaptive changes in mesotelencephalic dopaminergic
projections play a prominent role in the induction and expression
of amphetamine sensitization. Whereas sensitization can be in-
duced by microinjection of amphetamine into the ventral tegmen-
tal area, the cell body region of the mesolimbic dopaminergic
system (Kalivas and Weber, 1988; Perugini and Vezina, 1994;
Cador et al., 1995), its expression is associated with time-
dependent adaptations in forebrain dopaminergic terminal areas,
such as the nucleus accumbens and caudate putamen (Kolta et al.,
1985; Robinson et al., 1988; Wolf et al., 1993; Paulson and
Robinson, 1995). Dopaminergic neurotransmission in nucleus
accumbens and caudate putamen plays a critical role in the
locomotor and stereotypic effects of psychostimulant drugs, re-
spectively (Kelly et al., 1975; Pijnenburg et al., 1975; Sharp et al.,
1987; Delfs et al., 1990). Therefore, it is likely that hyperrespon-
siveness of striatal dopaminergic nerve terminals plays a major
role in the expression of psychostimulant sensitization. Indeed, in
particular, after extended post-treatment intervals (.1 week),
there appears to be a close correlation between hyperreactivity of
striatal dopaminergic neurotransmission and expression of behav-
ioral sensitization. On the other hand, inconsistencies in the
occurrence of these phenomena have been reported after short
post-treatment intervals (for review, see Pierce and Kalivas,
1997). In the present study, a single amphetamine exposure
induced hyperreactivity toward electrical depolarization of dopa-
minergic nerve terminals in the nucleus accumbens and caudate
putamen, an effect that increased between 3 d and 3 weeks after
treatment. This is consistent with findings reported after re-
peated amphetamine pretreatment, using both in vitro and in vivo
preparations (Kolta et al., 1985; Wolf et al., 1993; Paulson and
Robinson, 1995; Nestby et al., 1997). We observed a strong
relationship between hyperreactivity of accumbens dopaminergic
neurotransmission and expression of locomotor sensitization to
amphetamine, in that both phenomena gradually intensified with
prolonged withdrawal. On the other hand, at 3 d after treatment,
accumbens dopaminergic nerve terminals were markedly hyper-
reactive, but locomotor sensitization to amphetamine was only
marginal. A possible explanation for this could be that the ex-
pression of amphetamine sensitization depends on the balance
between dopamine neurotransmission in the nucleus accumbens
and medial prefrontal cortex. Thus, consistent with the effects of
repeated amphetamine pretreatment (Stephans and Yamamoto,
1995; L. J. M. J. Vanderschuren, unpublished observations), we
found that a single exposure to amphetamine resulted in an
enduring hyperreactivity of medial prefrontal dopaminergic
nerve terminals. Remarkably, however, hyperreactivity of medial
prefrontal dopaminergic nerve terminals decreased with pro-
longed withdrawal, displaying an opposite time course to the
hyperreactivity of accumbens dopaminergic terminals. Increased
dopaminergic neurotransmission in the medial prefrontal cortex
is known to inhibit accumbens dopaminergic neurotransmission,
as well as psychostimulant-induced locomotion (Louilot et al.,
1989; Vezina et al., 1991). It might therefore be that, especially
after a short post-treatment interval, hypersensitivity of medial
prefrontal dopaminergic terminals exerts an inhibitory influence
on the expression of amphetamine sensitization. Previous behav-
ioral and neurochemical studies (Banks and Gratton, 1995;
Prasad et al., 1999) support such a modulatory role of mesocor-
tical dopaminergic neurotransmission in the induction and ex-
pression of psychostimulant sensitization.
A single amphetamine exposure evoked enduring hyperreac-
tivity of cholinergic nerve terminals in nucleus accumbens and
caudate putamen, an effect that also occurred after repeated
amphetamine pretreatment (Nestby et al., 1997). Interestingly, an
increase in striatal acetylcholine release has been reported to
correlate with the expression of amphetamine sensitization (Bick-
erdike and Abercrombie, 1997). In addition, in striatal slices of
morphine-sensitized rats, enhanced cholinergic neurotransmis-
sion increased dopamine release through activation of presynap-
tic muscarinic receptors (Schoffelmeer et al., 1995). Because
striatal dopamine release can be stimulated by activation of
presynaptic muscarinic (Schoffelmeer et al., 1995; Smolders et al.,
1997) and nicotinic (Rowell et al., 1987; Mifsud et al., 1989;
Marshall et al., 1997) receptors, hyperreactivity of cholinergic
neurons may contribute to the expression of behavioral sensiti-
zation through a sustained stimulatory effect on striatal dopami-
nergic neurotransmission. Furthermore, interactions between do-
paminergic and cholinergic input into efferent striatal neurons
(Di Chiara et al., 1994) could also contribute to the expression of
behavioral sensitization.
The neuroendocrine consequences of a single exposure to
amphetamine were also similar to those after repeated amphet-
amine, i.e., in amphetamine-pretreated animals a hypersecretion
of ACTH and corticosterone was found after an amphetamine
challenge 3 weeks but not 3 d after treatment (Schmidt et al.,
1999; E. D. Schmidt, unpublished observations). Long-lasting
sensitization of the ACTH and corticosterone response to am-
phetamine may be involved in the autonomic and affective con-
sequences of amphetamine exposure, but a crucial role in the
expression of psychostimulant sensitization has been questioned
(Badiani et al., 1995; Johnson et al., 1995; Prasad et al., 1996;
Schmidt et al., 1999). On the other hand, the glucocorticoid
receptor antagonist mifepristone (RU486) blocked the expres-
sion of amphetamine sensitization (De Vries et al., 1996). Also,
glucocorticoid receptor activation enhances dopamine neuro-
transmission (Ronken et al., 1994; Piazza et al., 1996; Schof-
felmeer et al., 1997), whereas corticosterone may augment the
locomotor effects of psychostimulant drugs (Cador et al., 1993;
Marinelli et al., 1994, 1997; but see Badiani et al., 1995). There-
fore, a facilitatory role for central corticosteroid receptors in the
expression of amphetamine sensitization cannot be excluded.
Together, the present data suggest that a single exposure to
amphetamine is sufficient to induce long-lasting sensitization at
the behavioral, neurochemical, and neuroendocrine levels. Re-
peated exposure to drugs of abuse induces a complex pattern of
time-dependent adaptations in a variety of transmitter systems
and brain regions, ultimately resulting in long-lasting behavioral
sensitization (for review, see White et al., 1995; Pierce and Kali-
vas, 1997; Wolf, 1998). It has been hypothesized that this cascade
of neuroadaptations is driven by phasic alterations in gene ex-
pression. Mechanistic similarities between behavioral sensitiza-
tion and other forms of neuronal plasticity, such as long-term
memory, have been suggested. For instance, just like long-term
memory (Tully, 1998), the induction of long-lasting behavioral
sensitization requires novel protein synthesis (Karler et al., 1993;
Shimosato and Saito, 1993; Sorg and Ulibarri, 1995), structural
changes at relevant synapses (Robinson and Kolb, 1997), and is
most effectively induced by intermittent stimulation (Post, 1980;
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Robinson and Becker, 1986; Stewart and Badiani, 1993; Vander-
schuren et al., 1997). The present study adds another similarity
between long-term memory and long-lasting behavioral sensiti-
zation, in that both phenomena and their associated neuroadap-
tations can be induced by a single pertinent stimulus.
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